Guidance by physicians and pharmacists during antidepressant therapy: patients’ needs and suggestions for improvement

BMC Psychiatry

Research Article

Daniёlle C. Cath¹  Lennart J. Stoker²  Mariёtte Nederlof³  Toine C. G. Egberts⁴  Eibert R. Heerdink⁵ 

[1] Department of Medical Specialist Training, Drenthe Mental Health Institute, 9404 LA, Assen, The Netherlands;Department of Psychiatry, University Medical Center Groningen, 9713 GZ, Groningen, The Netherlands;Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands;Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands;Clinical Pharmacy, Brocacef Ziekenhuisfarmacie, 3600 AB, Maarssen, The Netherlands;Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands;Clinical Pharmacy, University Medical Center Utrecht, 3508 GA, Utrecht, The Netherlands;Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, P.O. Box 80082, 3508 TB, Utrecht, The Netherlands;Clinical Pharmacy, University Medical Center Utrecht, 3508 GA, Utrecht, The Netherlands;Research Group Innovation of Pharmaceutical Care, University of Applied Sciences Utrecht, 3508 AD, Utrecht, The Netherlands;

关键词: Qualitative research;    Focus groups;    Antidepressiva agents;    Second-generation;    Counseling;    Patient satisfaction;    Professional role;   

DOI  :  10.1186/s12888-017-1522-9

 received in 2017-06-07, accepted in 2017-10-26,  发布年份 2017

来源: Springer

【 摘 要 】

BackgroundGuidance of patients treated with antidepressants is paramount for successful therapy. The aim was to assess patients’ needs and suggestions for improvement of guidance by physicians and pharmacists during second generation antidepressant (SGA) therapy.MethodsFive focus group discussions were held with a total of 34 patients using an SGA. The discussions were conducted flexibly and responsively using a semi-structured topic list. All focus group discussions were video-recorded and transcripts were analyzed using ATLAS.ti for coding, thematic and open analysis.ResultsParticipants stated they were in need of better guidance. They suggested improving content of information during decisional moments, patient-health care professional communication and communication between health care professionals, and finally, organization of guidance. Barriers to achieving improved guidance were cited.ConclusionsContent, communication and organization of guidance are pivotal for achieving optimal guidance. Participants mentioned their current experienced guidance had limitations and brought up solutions for improvement. A next step would be to discuss the suggested solutions with health care professionals to assess their views and to discuss the possibility for implementation. After implementation, future studies could be aimed at determination of its impact on patients’ treatment efficacy, quality of life, treatment satisfaction and healthcare costs.

【 授权许可】

CC BY   
© The Author(s). 2017